 |  |  |  |  |  |
Emergency Filtration Products To Increase Production of NanoMask to Meet Growing
Demand Caused by Avian Flu Threat
HENDERSON, NEV, Oct. 10, 2005
Emergency Filtration Products, Inc. (EFP) (OTCBB: EMFP) today announced that it is planning to increase
production of its NanoMask due to a surge in demand. The company has placed an initial order for the
production of 500,000 filters from a West Coast based supplier. The filters, which are expected to be
manufactured within the next several weeks, will then be shipped to EFP's Henderson, Nevada facility
where they will be enhanced with nanoparticles and packaged.
Concurrently, the company expects to receive 50,000 mask shells from Taiwan and has placed an initial
order for an additional 100,000 mask shells from its Taiwanese supplier. At the first stage of its production
ramp up, EFP expects be able to assemble up to 50,000 masks and nano-enhance 200,000 filters per
week. The final assembly will be done in Henderson as soon as EFP receives the filters and mask shells.
EFP plans to further increase its production capacity as demand dictates.
"Over the past few weeks we have experienced a strong increase in orders for the NanoMask, which we
believe is due to the growing threat of a possible avian flu pandemic," said Douglas K. Beplate, President,
EFP. "As a result, and due to a number of potentially large orders from a number of medical products
distributors in the United States and abroad, we are gearing up production capacity to meet the growing
demand for the NanoMask."
About NanoMask
EFP's 2H Nano-Enhanced Environmental Mask, the NanoMask relies on the company's core 2H
Technology(TM) filtration system, which utilizes a combination of hydrophobic or hydrophilic filters able to
capture, isolate and or eradicate bacterial and viral microorganisms with efficiencies of 99.9%.
About Emergency Filtration Products (OTCBB: EMFP)
(http://www.emergencyfiltration.com/) is an air filtration products manufacturer whose patented 2H
Technology(TM) filter system has produced filtration efficiencies of 'greater than 99.99%' at a particulate
size of 0.027 microns. Its initial products were developed for the medical market: the Vapor Isolation
Valve(TM) and RespAide(R) CPR Isolation Mask used for resuscitation of respiratory/cardiac arrest cases;
and the 2H Breathing Circuit Filter for ventilators, respirators and anesthesia circuitry. Each has received
FDA approval. The Company also markets an Automated External Defibrillator Prep Kit featuring RespAide;
and the NanoMask(R), a nanotechnology enhanced environmental mask. In addition to filtration products,
the company supplies Superstat(R), a modified hemostatic collagen; to the US military for surgery and
extreme wound care.
Safe Harbor Statement
This release may contain statements that are forward looking. Such statements are made based upon
current expectations that are subject to risk and uncertainty. EFP does not undertake to update
forward-looking statements in this news release to reflect actual results of and changes in assumptions or
changes in other factors affecting such forward-looking information. The actual future results of the
company could differ significantly from such forward-looking statements. Sales may be dependent on the
success of future marketing campaigns, the signing of definitive agreements with additional distributors,
and both the perceived need for EFP's products and the competitive performance of such products in the
marketplace.
Demand Caused by Avian Flu Threat
HENDERSON, NEV, Oct. 10, 2005
Emergency Filtration Products, Inc. (EFP) (OTCBB: EMFP) today announced that it is planning to increase
production of its NanoMask due to a surge in demand. The company has placed an initial order for the
production of 500,000 filters from a West Coast based supplier. The filters, which are expected to be
manufactured within the next several weeks, will then be shipped to EFP's Henderson, Nevada facility
where they will be enhanced with nanoparticles and packaged.
Concurrently, the company expects to receive 50,000 mask shells from Taiwan and has placed an initial
order for an additional 100,000 mask shells from its Taiwanese supplier. At the first stage of its production
ramp up, EFP expects be able to assemble up to 50,000 masks and nano-enhance 200,000 filters per
week. The final assembly will be done in Henderson as soon as EFP receives the filters and mask shells.
EFP plans to further increase its production capacity as demand dictates.
"Over the past few weeks we have experienced a strong increase in orders for the NanoMask, which we
believe is due to the growing threat of a possible avian flu pandemic," said Douglas K. Beplate, President,
EFP. "As a result, and due to a number of potentially large orders from a number of medical products
distributors in the United States and abroad, we are gearing up production capacity to meet the growing
demand for the NanoMask."
About NanoMask
EFP's 2H Nano-Enhanced Environmental Mask, the NanoMask relies on the company's core 2H
Technology(TM) filtration system, which utilizes a combination of hydrophobic or hydrophilic filters able to
capture, isolate and or eradicate bacterial and viral microorganisms with efficiencies of 99.9%.
About Emergency Filtration Products (OTCBB: EMFP)
(http://www.emergencyfiltration.com/) is an air filtration products manufacturer whose patented 2H
Technology(TM) filter system has produced filtration efficiencies of 'greater than 99.99%' at a particulate
size of 0.027 microns. Its initial products were developed for the medical market: the Vapor Isolation
Valve(TM) and RespAide(R) CPR Isolation Mask used for resuscitation of respiratory/cardiac arrest cases;
and the 2H Breathing Circuit Filter for ventilators, respirators and anesthesia circuitry. Each has received
FDA approval. The Company also markets an Automated External Defibrillator Prep Kit featuring RespAide;
and the NanoMask(R), a nanotechnology enhanced environmental mask. In addition to filtration products,
the company supplies Superstat(R), a modified hemostatic collagen; to the US military for surgery and
extreme wound care.
Safe Harbor Statement
This release may contain statements that are forward looking. Such statements are made based upon
current expectations that are subject to risk and uncertainty. EFP does not undertake to update
forward-looking statements in this news release to reflect actual results of and changes in assumptions or
changes in other factors affecting such forward-looking information. The actual future results of the
company could differ significantly from such forward-looking statements. Sales may be dependent on the
success of future marketing campaigns, the signing of definitive agreements with additional distributors,
and both the perceived need for EFP's products and the competitive performance of such products in the
marketplace.
 |  |  |  |  |  |